Vitamin D Deficiency During Pregnancy Is Associated With Greater LDL ‐C Increase, Elevated β‐Hydroxybutyrate and Altered Neonatal Metabolic Markers—A Secondary, Pooled Analysis of the Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial ( DALI )
Vitamin-D-Mangel in der Schwangerschaft ist mit stärkerem LDL-C-Anstieg, erhöhtem β-Hydroxybutyrat und veränderten neonatalen Stoffwechselmarkern assoziiert – sekundäre gepoolte Analyse der randomisierten, kontrollierten Vitamin-D- and Lifestyle-for-Gestational-Diabetes-Prevention-Studie (DALI)
Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)
DOI: 10.1002/edm2.70258 ↗Auf einen Blick
Bei 962 Schwangeren mit Übergewicht oder Adipositas war ein Vitamin-D-Mangel vor der 20. SSW mit stärkeren LDL-C-Anstiegen und höherem β-Hydroxybutyrat verbunden. Im Nabelschnurblut waren die Ketonkörper höher, Lipide ähnlich.
Fragestellung
Ist der mütterliche Vitamin-D-Status vor der 20. Schwangerschaftswoche mit Lipid- und Stoffwechselverläufen in der Schwangerschaft und mit neonatalen Stoffwechselmarkern assoziiert?
Methode
Sekundäranalyse der randomisierten, kontrollierten DALI-Studie; Einteilung nach Vitamin-D-Status vor der 20. SSW; Messungen vor 20, in 24–28 und 35–37 SSW sowie im Nabelschnurblut.
Ergebnisse
962 Schwangere: 102 mit Vitamin-D-Mangel, 222 mit Insuffizienz, 638 mit Suffizienz. Im Vergleich zur Suffizienz waren bei Mangel die LDL-C-Anstiege in der Schwangerschaft und das β-Hydroxybutyrat in 24–28 SSW signifikant höher.
Schlussfolgerung der Autor:innen
Ein früher Vitamin-D-Mangel war mit veränderten maternalen Stoffwechselverläufen in der Schwangerschaft und höheren Ketonkörpern im Nabelschnurblut assoziiert. Kausale Zusammenhänge und klinische Bedeutung müssen weiter untersucht werden.
Kernaussagen
- Vitamin-D-Mangel vor 20 SSW: stärkere LDL-C-Anstiege
- β-Hydroxybutyrat in 24–28 SSW und im Nabelschnurblut höher
- Lipidkonzentrationen im Nabelschnurblut zwischen Gruppen ähnlich
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 13.08.2026. Verfasst von Jürgen Harreiter und 24 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Vitamin D Deficiency, 3-Hydroxybutyric Acid, Diabetes, Gestational, Cholesterol, LDL. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Community's 7th Framework Programme (FP7/2007-2013), Netherlands Organization for Health Research and Development (ZonMw), Polish Ministry of Science.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Vitamin D (vitD) plays a role in metabolic regulation, including lipid metabolism and insulin sensitivity. During pregnancy, profound physiological changes in lipid handling and ketogenesis occur to support fetal development. However, the extent to which maternal vitamin D status influences these metabolic adaptations and fetal metabolic markers remains unclear.
Methods
In this secondary analysis, we examined lipid distribution throughout pregnancy—from before 20 weeks' gestation to delivery—in women with overweight or obesity, stratified by vitamin D status (deficiency, insufficiency, or sufficiency), assessing both maternal and cord blood. Main inclusion criteria were: age > =18 years, singleton pregnancy, < 20 weeks' gestation, BMI ≥ 29 kg/m 2 . Women with GDM < 20 weeks' gestation were excluded. In total, 962 pregnant women were divided into vitD deficient (< 30 nmol/L, n = 102), insufficient (30–50 nmol/L, n = 222) and sufficient (> 50 nmol/L, n = 638) groups. VitD levels and lipid concentrations were assessed at < 20, 24–28 and 35–37 weeks' gestation and in cord blood.
Results
Compared with vitD sufficient women, women with vitD deficiency had significantly larger increases in LDL‐C throughout pregnancy and ß‐OH‐butyrate at 24–28 weeks' gestation, in adjusted analysis. VitD in cord blood was highest in offspring of mothers with vitD sufficiency. In cord blood, significantly higher ß‐OH‐butyrate was observed with vitD deficiency; lipid concentrations were similar between groups.
Conclusions
Early vitamin D deficiency before 20 weeks of gestation was associated with altered metabolic trajectories during pregnancy, including greater increases in LDL cholesterol and ketone body concentrations in women with overweight or obesity, as well as higher cord blood ketone levels in their offspring. These findings suggest that early maternal vitamin D status may influence maternal and fetal metabolic adaptations, although causal relationships and clinical implications require further investigation. Trial Registration Trial registered at ISRCTN registry ( https://doi.org/10.1186/ISRCTN70595832 ) trial number ISRCTN70595832. Registration date 02/12/2011
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- Department of Medicine, Landesklinikum Scheibbs, Scheibbs, Austria.
- Institut D'investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain.
- CIBER-BBN, ISCIII, Madrid, Spain.
- Macarthur Clinical School, Western Sydney University, Sydney, New South Wales, Australia.
- Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
ORCID-Profile: Jürgen Harreiter, David Simmons, Roland Devlieger, Annunziata Lapolla, Maria G Dalfra, David Hill, Rosa Corcoy, Alexandra Kautzky-Willer
Förderung
- European Community's 7th Framework Programme (FP7/2007-2013)
- Netherlands Organization for Health Research and Development (ZonMw)
- Polish Ministry of Science
- Odense University Free Research Fund
- NIHR Clinical Research Network
- CAIBER
- Spanish Diabetes Society (SED) XI Grant
- Medical Scientific Fund of the Mayor of Vienna
Zitieren
APA
Harreiter, J., Gisinger, T., Mendoza, L. C., Simmons, D., Desoye, G., Devlieger, R., Galjaard, S., Damm, P., Mathiesen, E. R., Jensen, D. M., Andersen, L. L. T., Dunne, F., Lapolla, A., Dalfra, M. G., Bertolotto, A., Wender-Ozegowska, E., Zawiejska, A., Hill, D., Jelsma, J. G. M., …, & Kautzky-Willer, A. (2026). Vitamin D Deficiency During Pregnancy Is Associated With Greater LDL ‐C Increase, Elevated β‐Hydroxybutyrate and Altered Neonatal Metabolic Markers—A Secondary, Pooled Analysis of the Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial ( DALI ). Endocrinology, Diabetes & Metabolism, 9(5). https://doi.org/10.1002/edm2.70258
Vancouver
Harreiter J, Gisinger T, Mendoza LC, Simmons D, Desoye G, Devlieger R, et al. Vitamin D Deficiency During Pregnancy Is Associated With Greater LDL ‐C Increase, Elevated β‐Hydroxybutyrate and Altered Neonatal Metabolic Markers—A Secondary, Pooled Analysis of the Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial ( DALI ). Endocrinology, Diabetes & Metabolism. 2026;9(5). doi:10.1002/edm2.70258
BibTeX
@article{Harreiter2026,
author = {Harreiter, Jürgen and Gisinger, Teresa and Mendoza, Lilian C and Simmons, David and Desoye, Gernot and Devlieger, Roland and Galjaard, Sander and Damm, Peter and Mathiesen, Elisabeth R and Jensen, Dorte M and Andersen, Lise Lotte T and Dunne, Fidelma and Lapolla, Annunziata and Dalfra, Maria G and Bertolotto, Alessandra and Wender-Ozegowska, Ewa and Zawiejska, Agnieszka and Hill, David and Jelsma, Judith G M and Snoek, Frank J and Worda, Christof and Bancher-Todesca, Dagmar and van Poppel, Mireille N M and Corcoy, Rosa and Kautzky-Willer, Alexandra},
title = {Vitamin D Deficiency During Pregnancy Is Associated With Greater LDL ‐C Increase, Elevated β‐Hydroxybutyrate and Altered Neonatal Metabolic Markers—A Secondary, Pooled Analysis of the Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial ( DALI )},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
volume = {9},
number = {5},
doi = {10.1002/edm2.70258}
}
EUVIMED